RTX A/S
Noerresundby, Denmark, 5 March 2021
Announcement no. 17/2021
The Board of Directors of RTX has, cf. company announcement no. 38 dated 25. November 2020, resolved to initiate a share buy-back programme in accordance with the provisions of Article 5 Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (MAR) and the Commission’s delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the "Safe Harbor" rules.
Under the programme RTX will buy back shares for an amount up to DKK 50 million and no more than 500,000 shares in the period from 25 November 2020 to 30 September 2021.
The following transactions have been made under the programme in the period from 26 February 2021 to 4 March 2021:
| Number of shares | Average purchase price | Transaction value in DKK | |
| Accumulated, latest announcement | 114,200 | 210.25 | 24,010,684 |
| 26 February 2021 | 2,300 | 186.11 | 428,053 |
| 1 March 2021 | 2,300 | 188.16 | 432,768 |
| 2 March 2021 | 2,000 | 187.13 | 374,260 |
| 3 March 2021 | 2,000 | 185.70 | 371,400 |
| 4 March 2021 | 2,000 | 181.63 | 363,260 |
| Accumulated under the programme | 124,800 | 208.18 | 25,980,425 |
With the transactions stated above, RTX A/S owns a total of 370,186 of treasury shares, corresponding to 4.28% of the share capital. The total number of shares in the company is 8,642,838 including treasury shares.
In accordance with the Regulation (EU) No. 596/2014, transactions related to the share buy-back programme are presented in detailed form in the appendix attached to this company announcement.
Enquiries and further information:
CEO Peter Røpke, tel +45 96 32 23 00
RTX’s homepage: www.rtx.dk
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
DBV Technologies S.A.17.1.2026 00:11:29 CET | Press release
DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing
Scandinavian Investment Group A/S16.1.2026 22:01:00 CET | Pressemeddelelse
Storaktionærmeddelelse
Scandinavian Investment Group A/S16.1.2026 22:00:00 CET | Pressemeddelelse
Ledende medarbejders transaktion
Tiziana Life Sciences Ltd.16.1.2026 20:45:30 CET | Press release
Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares
Genmab A/S16.1.2026 19:30:00 CET | Press release
Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
